Related Experiment Video

Updated: Jun 23, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.7K

G-DISCO: Gemcitabine-Docetaxel Intravesical Synchronous CO-administration - a phase 1 study protocol

Kevin G Keane1,2,3, Cynthia Hawks1,2,3, Steve P McCombie1,2,3

  • 1UWA Medical School, University of Western Australia, Perth, WA, Australia.

BJU International
|October 28, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.9K
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.6K

Related Experiment Videos

Last Updated: Jun 23, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.7K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.9K
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.6K

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Articles linked to this work by shared authors, journal, and citation graph.

Evaluating mucosal and systemic immunity in an observational cohort of South African children hospitalized with acute respiratory tract infections.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin-naïve Non-muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301).

European urology·2026

Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia.

Asia-Pacific journal of clinical oncology·2026

Service utilisation and outcomes of transfers by a specialised paediatric and neonatal retrieval service in the Western Cape, South Africa.

African journal of emergency medicine : Revue africaine de la medecine d'urgence·2025

The role of gemcitabine-docetaxel in the management of NMIBC: a scoping review of current status and future directions.

Expert review of anticancer therapy·2025

The role of immune checkpoint inhibitors in the management of NMIBC: a scoping review of current status and future direction.

Expert review of anticancer therapy·2025

Antegrade versus retrograde ureteroscopy for large proximal ureteric stones: a meta-analysis.

BJU international·2026

Evaluation of triplet therapy combined with robot-assisted cytoreductive prostatectomy for high-volume metastatic prostate cancer: a multicentre randomised controlled trial protocol.

BJU international·2026

Immediate intraoperative detrusor muscle status at primary transurethral resection of bladder tumour: a prospective, blinded, paired cohort, feasibility study using fluorescence confocal microscopy (IB1-LaserComplete study).

BJU international·2026

Spontaneous stone passage prediction in acute ureteric colic using radiomics and machine learning.

BJU international·2026

Real-time artificial intelligence-based anatomy recognition in single-port transvesical enucleation of the prostate.

BJU international·2026

Long-term oncological outcomes from a prospective cohort of patients with localised prostate cancer.

BJU international·2026

Effect of Adding Erector Spinae Plane Block to a Multimodal Analgesic Regimen on Quality of Recovery After Laparoscopic Colon Cancer Surgery: A Prospective Randomized Controlled Trial.

Journal of pain research·2026

Squamous Eccrine Ductal Carcinoma Treated With Adjuvant Radiation Therapy.

Cureus·2026

Pulmonary resection post-coronary artery bypass grafting: Feasible, but right-sided procedures demand caution.

JTCVS open·2026

Transitioning from neoadjuvant chemoradiation to perioperative chemotherapy for esophageal adenocarcinoma: Impact on margins and pathologic outcomes.

JTCVS open·2026

Total neoadjuvant therapy for rectal cancer: where are we now, where do we go?

Clinical and translational radiation oncology·2026

Sequential Application of Transpupillary Thermal Therapy and Cryotherapy in the Management of Small Choroidal Melanoma: A Pilot Evaluation of Efficacy and Safety.

Journal of vitreoretinal diseases·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us